Biogened S.A. (WSE:BGD)
Poland · Delayed Price · Currency is PLN 20.80
0.00 (0.00%)
At close: Jul 24, 2026
Biogened Revenue
In the year 2025, Biogened had annual revenue of 114.04M PLN with 2.81% growth. Biogened had revenue of 28.19M in the quarter ending December 31, 2025, a decrease of -3.68%.
Revenue
114.04M
Revenue Growth
+2.81%
P/S Ratio
0.47
Revenue / Employee
595.07K
Employees
184
Market Cap
51.09M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 114.04M | 3.11M | 2.81% |
| Dec 31, 2024 | 110.93M | 15.37M | 16.09% |
| Dec 31, 2023 | 95.56M | 15.94M | 20.02% |
| Dec 31, 2022 | 79.62M | 14.30M | 21.89% |
| Dec 31, 2021 | 65.32M | 16.99M | 35.15% |
| Dec 31, 2020 | 48.33M | 1.70M | 3.64% |
| Dec 31, 2019 | 46.63M | 6.39M | 15.88% |
| Dec 31, 2018 | 40.24M | 6.67M | 19.86% |
| Dec 31, 2017 | 33.57M | 4.96M | 17.33% |
| Dec 31, 2016 | 28.61M | -1.24M | -4.16% |
| Dec 31, 2015 | 29.86M | 7.21M | 31.84% |
| Dec 31, 2014 | 22.65M | 224.75K | 1.00% |
| Dec 31, 2013 | 22.42M | -3.29M | -12.79% |
| Dec 31, 2012 | 25.71M | 914.81K | 3.69% |
| Dec 31, 2011 | 24.79M | 3.52M | 16.56% |
| Dec 31, 2010 | 21.27M | -3.97M | -15.74% |
| Dec 31, 2009 | 25.25M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| MLK Foods Public Company LTD | 331.63M |
| IZOBLOK | 315.60M |
| ORGANIC Farma Zdrowia | 139.70M |
| KSG Agro | 64.23M |
| Telestrada | 58.59M |
| Moliera2 | 51.48M |
| 7FIT S.A. | 40.41M |
| Quart Development | 6.74M |